ATLANTA — The remarkable ability of CAR-T therapies to eradicate cancer cells from desperately ill patients does not come without serious safety risks, notably the inflammatory storm called cytokine release syndrome and neurological side effects, including confusion and swelling of the brain. Currently, CAR-T therapy is administered in the hospital so admitted patients can be monitored closely for any warning signs. This adds costs to the already expensive treatment.

It also raises a key question: As CAR-T therapy evolves, will it ever become safe enough so patients can be treated and cared for outside the hospital?

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.